These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3473911)

  • 1. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder.
    Casper RC; Swann AC; Stokes PE; Chang S; Katz MM; Garver D
    Acta Psychiatr Scand; 1987 Mar; 75(3):243-50. PubMed ID: 3473911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol measures in primary major depressive disorder with hypersomnia or appetite increase.
    Casper RC; Kocsis J; Dysken M; Stokes P; Croughan J; Maas J
    J Affect Disord; 1988; 15(2):131-40. PubMed ID: 2975683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL; Price LH; Charney DS; Heninger GR
    Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma postdexamethasone cortisol levels in schizoaffective disorder.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Psychiatry Res; 1988 Oct; 26(1):35-42. PubMed ID: 3237905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
    Hudson JI; Pope HG; Jonas JM; Laffer PS; Hudson MS; Melby JC
    Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple depressive episodes and plasma postdexamethasone cortisol levels.
    Meador-Woodruff JH; Gurguis G; Grunhaus L; Haskett RF; Greden JF
    Biol Psychiatry; 1987 May; 22(5):583-92. PubMed ID: 3580433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
    Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression.
    Roy A; Pickar D; De Jong J; Karoum F; Linnoila M
    Arch Gen Psychiatry; 1988 Sep; 45(9):849-57. PubMed ID: 3415426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
    Gwirtsman HE; Roy-Byrne P; Gitlin MJ; Halaris A; Ahles S
    J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Acta Psychiatr Scand; 1990 Apr; 81(4):364-71. PubMed ID: 2343764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP; Haskett RF; Albala AA; Carroll BJ; Lohr NE
    Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder.
    Rhebergen D; Korten NC; Penninx BW; Stek ML; van der Mast RC; Oude Voshaar R; Comijs HC
    Psychoneuroendocrinology; 2015 Jan; 51():341-50. PubMed ID: 25462906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of weight change on the dexamethasone suppression test in depressed and anorexic patients.
    Schweitzer I; Maguire KP; Tiller JW; Gee AH; Harrison LC; Davies BM
    Br J Psychiatry; 1986 Dec; 149():751-5. PubMed ID: 3790873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
    J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 20. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.